Canada Pension Plan Investment Board
TRVI icon

Canada Pension Plan Investment Board’s Trevi Therapeutics TRVI Stock Holding History

Canada Pension Plan Investment Board’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-15,000
Closed -$36K – 1543
2020
Q4 		$36K Buy
+15,000
New +$48.6K ﹤0.01% 1287
2020
Q3 		– Sell
-40,000
Closed -$263K – 1355
2020
Q2 		$263K Buy
+40,000
New +$141K ﹤0.01% 1155

Other funds holding TRVI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WA
WealthTrust Axiom Wayne, Pennsylvania $406M AUM 40.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Canada Pension Plan Investment Board's TRVI Position: Q1 2021 in Review

Canada Pension Plan Investment Board sold out of Trevi Therapeutics (TRVI) in Q1 2021, closing a stake of 15,000 shares — an estimated $36K sold.

Canada Pension Plan Investment Board first reported a position in TRVI in Q2 2020 and held it in 2 quarters. The position peaked at $263K in Q2 2020. 19 funds tracked by Wall St. Rank hold TRVI as of Q1 2021.

  • Canada Pension Plan Investment Board reported no remaining Trevi Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 15,000 Trevi Therapeutics shares in Q1 2021, an estimated $36K.
  • Canada Pension Plan Investment Board first reported a position in Trevi Therapeutics in Q2 2020 and held it in 2 quarters.
  • Canada Pension Plan Investment Board's Trevi Therapeutics position peaked at $263K in Q2 2020.
  • 19 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q1 2021.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2021, filed 17 May 2021.